1 (−2 3; -1 8) Qs     22,140 23,489 24,343 26,108 26,984 28,303 2

1 (−2.3; -1.8) Qs     22,140 23,489 24,343 26,108 26,984 28,303 28,959 30,800 +12.9 (12.7; 13.2) Total ITALY Ms + Qs     37,894 39,254 39,669 41,028 41,097 42,258 42,691 44,997 AZD1080 nmr +2.2 (2.0; 2.3)

Data are reported by selleck chemicals region and macro-area (Northern, Central, and Southern Italy). 1 Reported data are absolute numbers unless otherwise specified. 2 AAPC: Average Annual Percentage Change and 95% Confidence Interval. *Percentage of women aged 50–69 years old (on total screening target population) invited to perform mammographic screening in 2007–2008 (2-year cumulative data).18 § Adherence rate to mammography screening in year 2008 (adjusted by excluding women performing mammography outside official programs).16 Percentages of coverage and adherence to mammographic screening in 2007–08 are also reported.16 Quadrantectomies significantly increased across all the Regions but Valle D’Aosta and Abruzzo. When macro-areas were considered, the most remarkable increase was reported for Southern Regions (+3.3%, 3.0–3.5;+3.9%, 3.5–4.3 and +7.2%, 6.8–7.7 for Northern, Central and Southern regions, respectively). In Table 4, we report mastectomies and quadrantectomies performed on repeated admissions

in the same year between 2001 and 2008. Overall, a total number of 46,610 repeated breast surgeries was performed Selleckchem AZD1152 in Italy between 2001 and 2008. Our data showed a significant increase in any of the subcategories considered but the first one (i.e., subcategory including women who underwent repeated breast surgery once within the Ixazomib manufacturer same year). Table 4 1 Mastectomies

and 1 Quadrantectomies performed on repeated admissions between 2001 and 2008 Re-interventions (n) in the same patient 2001 2002 2003 2004 2005 2006 2007 2008 AAPC (95%CI)2 1 re-intervention in the same year 3268 3243 3241 3039 2950 2667 2347 1796 −6.8 (−7.3; -6.3) 2 re-interventions in the same year 1387 1981 2419 2834 3092 3484 3560 3794 +12.9 (12.2; 13.5) 3 re-interventions in the same year 27 56 132 166 220 240 290 295 +27.5 (24.4; 30.7) >3 re-interventions in the same year 0 0 7 3 17 16 15 24 +45.9 (29.9; 63.9) Total Re-interventions 4682 5280 5799 6042 6279 6407 6212 5909 +3.2 (2.8; 3.6) Data is presented by categories defined upon the number of repeat major breast surgeries within a year. 1 Reported data are absolute numbers unless otherwise specified. 2AAPC: Average Annual Percentage Change (with 95% Confidence Interval, CI). Discussion In the present study, data from the NHDRs proved a valuable tool in the ascertainment of the real figures of incident breast cancer cases. Indeed, the current indications for quadrantectomies or mastectomies in operable breast cancer, along with the use of well defined codes assigned to breast surgeries at the time of patient discharge, render breast cancer particularly prone to traceability through NHDRs. Based on our results, mastectomies decreased in all the age groups but two (i.e.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>